Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_assertion type Assertion NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_head.
- NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_assertion wasGeneratedBy ECO_0000203 NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_provenance.
- NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_assertion wasDerivedFrom befree-20140225 NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_provenance.
- NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_assertion SIO_000772 21463107 NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_provenance.
- NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_assertion evidence source_evidence_literature NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_provenance.
- NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_assertion description "[In conclusion, the incidence of optimal cytogenetic response or early-MMR in patients with CML-CP treated with IM for 6 months was significantly higher in those with a trough level of ≥ 1000 compared with those with a level of <1000.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206975.RAvb2mG36_jZT5e65Yoxhc7pF14mtIkqH5-blDBYZhnXA130_provenance.